DE-ESCALATING THERAPY IN PATIENTS WITH CROHN'S DISEASE RECEIVING ADALIMUMAB: SUBGROUP ANALYSIS OF THE CALM STUDY

被引：1

作者：

Bossuyt, P. ^{[1
]}

D'Haens, G. ^{[2
]}

Panaccione, R. ^{[3
]}

Sandborn, W. ^{[4
]}

Reinisch, W. ^{[5
]}

Travis, S. ^{[6
]}

Schreiber, S. ^{[7
]}

Armuzzi, A. ^{[8
]}

Danese, S. ^{[9
]}

Berg, S. ^{[10
]}

Petersson, J. ^{[11
]}

Maa, J-F ^{[11
]}

Neimark, E. ^{[11
]}

Colombel, F. ^{[12
]}

机构：

[1] Imelda Gen Hosp, Bonheiden, Belgium

[2] Acad Med Ctr, Amsterdam, Netherlands

[3] Univ Calgary, Calgary, AB, Canada

[4] Univ Calif San Diego, La Jolla, CA 92093 USA

[5] Med Univ Vienna, Vienna, Austria

[6] Oxford Univ Hosp, Oxford, England

[7] Univ Hosp Schleswig Holstein, Kiel, Germany

[8] Fdn Policlin Gemelli Univ, Rome, Italy

[9] Humanitas Univ, Rozzano, Italy

[10] AbbVie, Solna, Sweden

[11] AbbVie Inc, N Chicago, IL USA

[12] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

GUT | 2019年 / 68卷

关键词：

D O I：

10.1136/gutjnl-2019-BSGAbstracts.136

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PTH-077

引用

页码：A70 / A71

页数：2

共 50 条

[31] Adalimumab Monotherapy Versus Combination Therapy With Adalimumab and Immunomodulators for Crohn's Disease: A Meta-Analysis
Kopylov, Uri
Al-Taweel, Talal
Yaghoobi, Mohammad
Bitton, Alain
Lakatos, Peter L.
Ben-Horin, Shomron
Seidman, Ernest G.
Afif, Waqqas
GASTROENTEROLOGY, 2014, 146 (05) : S201 - S201
[32] Observational Study of Treatment Patterns in Patients Newly Initiated with Adalimumab or Infliximab Therapy for Crohn's Disease
Plevy, Scott
Lu, M.
Yu, Andrew
Sharma, Hari
Chao, Jingdong
Mulani, Parvez
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S479 - S479
[33] A Case of Molluscum Contagiosum Infection in a Patient with Crohn's Disease, Receiving Combination Therapy with Azathioprine and Adalimumab
Cintolo, Marcello
Guarneri, Claudio
Lentini, Maria
JOURNAL OF CROHNS & COLITIS, 2015, 9 (07): : 593 - 594
[34] Adalimumab for the treatment of fistulas in patients with Crohn's disease
Colombel, J-F
Schwartz, D. A.
Sandborn, W. J.
Kamm, M. A.
D'Haens, G.
Rutgeerts, P.
Enns, R.
Panaccione, R.
Schreiber, S.
Li, J.
Kent, J. D.
Lomax, K. G.
Pollack, P. F.
GUT, 2009, 58 (07) : 940 - 948
[35] Ustekinumab Versus Adalimumab in Patients With Crohn's Disease
Segal, Jonathan P.
GASTROENTEROLOGY, 2022, 163 (04) : 1115 - 1116
[36] Adalimumab for the Treatment of Fistulas in Patients with Crohn's Disease
Fine, Steven N.
INFLAMMATORY BOWEL DISEASES, 2011, 17 (02) : 667 - 668
[37] Efficacy of Adalimumab in Korean Patients with Crohn's Disease
Sohn, Il Woong
Kim, Sung Tae
Kim, Bun
Lee, Hyun Jung
Park, Soo Jung
Hong, Sung Pil
Kim, Tae Il
Kim, Won Ho
Cheon, Jae Hee
GUT AND LIVER, 2016, 10 (02) : 255 - 261
[38] Antibodies to Adalimumab Predict Inflammation in Crohn's Patients on Maintenance Adalimumab Therapy
Baert, Filip J.
Lockton, Steven
Hauenstein, Scott
Singh, Sharat
Gils, Ann
Vermeire, Severine
GASTROENTEROLOGY, 2014, 146 (05) : S242 - S242
[39] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
Cordero Ruiz, Patricia
Castro Marquez, Cristina
Mendez Rufian, Vanesa
Castro Laria, Luisa
Caunedo Alvarez, Angel
Romero Vazquez, Javier
Herrerias Gutierrez, Juan Manuel
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
[40] Safety of Adalimumab in patients with Crohn's Disease: Analysis of global clinical trials
Colombel, J.
Pannaccione, R.
Sandbom, W.
Rutgeerts, P.
Hanauer, S.
Reinisch, W.
Pollack, P.
Kent, J.
Cardoso, A.
Lau, W.
INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S25 - S25

← 1 2 3 4 5 →